Correlation between malondialdehyde and metanephrine in patients with acute lymphoblastic leukemia

Abstract EN

Acute lymphoblastic leukemia (ALL) is one of the most common diseases , so in this study the serum level of malondialdehyde and its relationship with metanephrine was investigated in acute lymphoblastic leukemia patients over one month of treatment.

Some biochemical parameters (serum glucose, total serum protein, malondialdehyde, vitamin C, and metanephrine) changed as well as white blood cell count and blood hemoglobinlevelswere analyzed in sixty patients diagnosed with acute lymphoblastic leukemia over one month of treatment compared to healthy control group.

Statistically significant increases (p < 0.01) in white blood cell (WBC) count, mean concentrations of malondialdehyde (MDA) (p < 0.05) and metanephrine (p < 0.001) were observed in contrast significant decreases in blood hemoglobin (p < 0.001), random blood glucose (p < 0.01) and total serum protein (p < 0.01) were determined in ALL patients group than that control group.

Meanwhile the results showed a positive correlation (p < 0.001)between metanephrine and MDA in ALL patients in comparison to control.

The results in the present study indicate a possible link between increased metanephrine levels of cells alterations due to oxidative damage.